157 related articles for article (PubMed ID: 25596010)
1. The Refusal of Palliative Radiation in Metastatic Non-Small Cell Lung Cancer and Its Prognostic Implications.
Stavas MJ; Arneson KO; Ning MS; Attia AA; Phillips SE; Perkins SM; Shinohara ET
J Pain Symptom Manage; 2015 Jun; 49(6):1081-1087.e4. PubMed ID: 25596010
[TBL] [Abstract][Full Text] [Related]
2. Refusal of radiation therapy and its associated impact on survival.
Hamidi M; Moody JS; Kozak KR
Am J Clin Oncol; 2010 Dec; 33(6):629-32. PubMed ID: 20216302
[TBL] [Abstract][Full Text] [Related]
3. Refusal of curative radiation therapy and surgery among patients with cancer.
Aizer AA; Chen MH; Parekh A; Choueiri TK; Hoffman KE; Kim SP; Martin NE; Hu JC; Trinh QD; Nguyen PL
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):756-64. PubMed ID: 24803037
[TBL] [Abstract][Full Text] [Related]
4. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
6. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
Berghmans T; Tragas G; Sculier JP
Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
9. Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.
Kim HJ; Kim YJ; Seo MD; Yi HG; Lee SH; Lee SM; Kim DW; Yang SC; Lee CT; Lee JS; Kim YW; Heo DS
Lung Cancer; 2009 Aug; 65(2):242-6. PubMed ID: 19147252
[TBL] [Abstract][Full Text] [Related]
10. Safety and palliative efficacy of single-dose 8-Gy reirradiation for painful local failure in patients with stage IV non-small cell lung cancer previously treated with radical chemoradiation therapy.
Topkan E; Yildirim BA; Guler OC; Parlak C; Pehlivan B; Selek U
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):774-80. PubMed ID: 25752391
[TBL] [Abstract][Full Text] [Related]
11. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
12. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
[TBL] [Abstract][Full Text] [Related]
13. Utilization pattern and service settings of palliative care for patients with metastatic non-small cell lung cancer.
Huo J; Hong YR; Turner K; Bian J; Grewal R; Wilkie DJ
Cancer; 2019 Dec; 125(24):4481-4489. PubMed ID: 31449674
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy patterns of care for stage I and II non-small cell lung cancer in Sydney, Australia.
Nguyen AD; Wong W; Beydoun N; Mohan S; Shafiq J; Vinod SK
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):131-141. PubMed ID: 30281917
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated three-dimensional conformal radiation therapy alone for centrally located cT1-3N0 non-small-cell lung cancer.
Oh D; Ahn YC; Kim B; Pyo H
J Thorac Oncol; 2013 May; 8(5):624-9. PubMed ID: 23584294
[TBL] [Abstract][Full Text] [Related]
16. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer.
Wisnivesky JP; Bonomi M; Henschke C; Iannuzzi M; McGinn T
Chest; 2005 Sep; 128(3):1461-7. PubMed ID: 16162744
[TBL] [Abstract][Full Text] [Related]
18. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
19. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
[TBL] [Abstract][Full Text] [Related]
20. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
